Can a COPD inhaler also help your heart?
NCT ID NCT07073950
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a triple-combination inhaler (budesonide, glycopyrronium, and formoterol) against a placebo in 56 people with COPD and lung hyperinflation. The goal is to see if the inhaler improves both lung function and heart function, measured by MRI. Participants will receive the inhaler or placebo in a crossover design, meaning everyone gets both treatments at different times.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Budesonide/Glycopyrronium/Formoterol fumarate (a triple-combination inhaler)
What this could lead to
If it works, this could show that the inhaler improves both lung and heart function in people with COPD and hyperinflation, potentially leading to better management of the disease.
What could go wrong
This is a small, early-phase 4 trial with only 56 participants, so results may not apply to everyone. The study is also short-term, so long-term benefits or risks are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGAhrensburg, 22926, Germany
-
Research Site
RECRUITINGBerlin, 14050, Germany
-
Research Site
NOT_YET_RECRUITINGFrankfurt, 60596, Germany
-
Research Site
RECRUITINGHanover, 30625, Germany
-
Research Site
WITHDRAWNHarefield, UB9 6JH, United Kingdom
-
Research Site
RECRUITINGLondon, W1T 6AH, United Kingdom
-
Research Site
RECRUITINGManchester, M23 9QZ, United Kingdom